As Gavi plans next five-year strategy, it must do more to get vaccines to people excluded from vaccination
April 16, 2024With routine vaccination efforts failing to reach people in fragile and emergency settings, MSF is seeing low vaccination coverage and more outbreaks of vaccine-preventable diseases, like diphtheria and measles Geneva, 15 April 2024 – Ahead of Gavi, the Vaccine Alliance’s Board...
Read more
MSF response to signing of EFTA-India trade agreement
March 12, 2024Geneva/Delhi, 12 March 2024: On 10 March 2024, it was announced that India and the European Free Trade Association (EFTA) signed a free trade agreement (FTA) they have been negotiating since 2006. Full text of agreement along with Annex and the Record...
Read more
MSF warns governments are failing to test, treat and prevent TB in children
November 14, 2023Governments must immediately implement the latest WHO guidelines to stop children from dying from this deadly yet curable disease Geneva, 14 November 2023 - Médecins Sans Frontières/Doctors Without Borders (MSF) welcomed the World Health Organization’s (WHO) ‘Roadmap towards ending TB in...
Read more
MSF responds to groundbreaking news that Johnson & Johnson will not enforce patents on key TB drug bedaquiline in low- and middle-income countries
September 30, 202330 September 2023, Geneva Christophe Perrin, TB Advocacy Pharmacist, MSF Access Campaign: “We welcome Johnson & Johnson’s (J&J) announcement finally paving the way for unfettered access to affordable generic versions of bedaquiline for all people living with drug-resistant tuberculosis (DR-TB) who need...
Read more
MSF: TB test price reduction by Cepheid and Danaher is an important step in the right direction
September 19, 2023Cepheid and its parent company Danaher announced today that they are reducing the price of the Xpert MTB/RIF test for TB by 20 percent in high-TB-burden countries from US$9.98 to $7.97 per test. This reduction is a significant step, considering the...
Read more
Ahead of UN TB High-Level Meeting, US corporations J&J and Cepheid must pledge access to lifesaving TB medicines and tests for everyone in need
September 12, 2023TB is curable but remains the world’s leading infectious disease killer 12 September 2023, Geneva/New York – Next week, world leaders meet for the second-ever global tuberculosis (TB) High-Level Meeting at the United Nations (UN) in New York, to endorse...
Read more
MSF South Asia Health and Humanity Summit: Partnering to build better responses during emergencies
August 17, 202317 August 2023, New Delhi: Setting the agenda for a paradigm shift in health and humanitarian considerations during emergencies, especially in South and Southeast Asia, over 15 practitioners, thought leaders, artists, and over 300 attendees from the social impact space...
Read more
Transforming lives in Mozambique: surgical treatment for patients with neglected diseases in Mogovolas district
July 25, 2023Nampula, July 21 , 2023 – Médecins Sans Frontières/Doctors Without Borders (MSF) is collaborating with the District Services of Health, Women and Social Action in Mogovolas and the Provincial Services in Nampula, Mozambique, to deliver surgical treatment for hydrocele, one...
Read more
Gavi must do more as WHO/UNICEF estimates show slow childhood vaccination recovery
July 19, 2023Gavi should waive co-financing requirements for countries with fragile health systems or in humanitarian crises.Geneva, 18 July, 2023 — Today, Médecins Sans Frontières/Doctors Without Borders (MSF) again called on Gavi, the Vaccine Alliance to broaden “catch-up” vaccine coverage for unprotected...
Read more
MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics
July 18, 2023MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics. Recent deal offering controlled generics access in limited countries does not go...
Read more
TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries
July 14, 2023Christophe Perrin, TB advocacy pharmacist, MSF Access Campaign "Today's announcement by the Stop TB Partnership/Global Drug Facility about a deal with pharmaceutical corporation Johnson & Johnson (J&J), for access to affordable generic versions of the lifesaving tuberculosis (TB) drug bedaquiline, offers...
Read more
MSF calls on Gavi to step up efforts to improve vaccine access for children up to at least five years old
June 12, 2023Geneva, 12 June 2023 – Médecins Sans Frontières/Doctors Without Borders (MSF) today again urged Gavi, the Vaccine Alliance, to urgently prioritise reaching ‘zero-dose’* and under-immunised children up to age five, by removing barriers to broadening vaccine coverage for unprotected children,...
Read more
